Pep Talk
October 10th 2023
New product: Highly bioactive FGF-1 now available
We have launched FGF-1 as part of our FGF family range. FGF-1 is involved in embryonic development, tissue regeneration, and wound healing. It can used for the maintenance of various cells such as mesenchymal cells, hematopoietic cells, and glial cells. Manufactured in our Cambridge facility, this animal-free recombinant protein is highly pure, bioactive and with excellent lot-to-lot consistency.
Featured product: Innovative FGF2-G3
Thermostable FGF2-G3 is hyper stable at 37°C enabling more reproducible stem cell cultures.
This animal-free recombinant protein has been engineered to increase the half-life of FGF-2 from <10 hrs to >7 days in culture, allowing you to follow weekend-free cell culture protocols, and giving you the confidence that your FGF-2 is bioactive for the duration of your culture.
Qkine partners with CARMA to revolutionize sustainable food production
Qkine recently announced a new partnernship with the UK’s new £12M cellular agriculture manufacturing hub, CARMA. The EPSRC-funded Cellular Agriculture Manufacturing Hub, a multidisciplinary consortium led by Prof Marianne Ellis, University of Bath, will develop new approaches to making food products, ultimately creating an environmentally, economically, and socially sustainable model in which novel manufacturing systems complement traditional food production.
Qkine appoints European distribution partner CliniSciences
Qkine is pleased to announce its sales distribution agreement with industry-leading European distributor, CliniSciences. With a diverse portfolio of companies operating across Europe, CliniSciences is well-positioned to serve the needs of European customers wanting to purchase Qkine proteins.
Sign up to hear about the latest in growth factor innovation, new products and cool stem cell science
We respect your time! You will receive update emails only when there is something important to say. Our privacy policy is available here. You can unsubscribe at any time.
